Geftib 250 mg Tablet

Geftib 250 mg Tablet is an antineoplastic medication classified as a tyrosine kinase inhibitor, with Gefitinib as its active ingredient. It is primarily prescribed for the treatment of non-small cell lung cancer (NSCLC), a type of lung cancer characterized by the uncontrolled and abnormal growth of cells in lung tissue.

This medicine is specifically used in patients whose cancer has spread (metastasized) to other parts of the body, particularly those with abnormal EGFR (epidermal growth factor receptor) gene mutations, and who have not received prior cancer treatment.

Specific formulations of Geftib may contain lactose as an inactive ingredient. Individuals with lactose intolerance, a condition in which the body is unable to digest lactose, a sugar found in milk, may experience symptoms such as bloating, gas, and abdominal discomfort. It is important to inform your doctor if you have lactose intolerance before starting this medication.

Before initiating therapy, you should discuss your full medical history with your healthcare provider, especially if you have existing liver or kidney problems, lung conditions, vision issues, or if you are taking blood-thinning medications like warfarin. Routine blood tests will be conducted during treatment to monitor your response and minimize the risk of side effects. Alcohol consumption should be avoided, as it may increase the risk of dizziness and other adverse effects.

Geftib 250 mg Tablet is not safe for use during pregnancy. It may cause harm to an unborn baby. If you are pregnant or planning to become pregnant, inform your doctor. A pregnancy test may be required before starting treatment. Your doctor will advise you on effective contraceptive methods, which must be used during treatment and for at least two weeks after the last dose.

Additionally, breastfeeding is not recommended while using this medicine, as it is not yet known whether the drug passes into breast milk and affects the infant.

Always use this medication under the supervision of a qualified healthcare professional and follow the prescribed dosage and precautions carefully.